Please use this identifier to cite or link to this item: http://hdl.handle.net/10553/53606
DC FieldValueLanguage
dc.contributor.authorShimada, Masayuki
dc.contributor.authorHernandez-Gonzalez, Inmaculada
dc.contributor.authorGonzalez-Robayna, Ignacio
dc.contributor.authorRichards, JoAnne S.
dc.contributor.otherHernandez Gonzalez, Inmaculada
dc.contributor.otherShimada, Masayuki
dc.contributor.otherGonzalez Robayna, Ignacio
dc.date.accessioned2019-02-04T17:24:07Z-
dc.date.available2019-02-04T17:24:07Z-
dc.date.issued2006
dc.identifier.issn0888-8809
dc.identifier.urihttp://hdl.handle.net/10553/53606-
dc.description.abstractThe molecular bridges that link the LH surge with functional changes in cumulus cells that possess few LH receptors are being unraveled. Herein we document that epidermal growth factor ( EGF)- like factors amphiregulin ( Areg), epiregulin ( Ereg), and betacellulin ( Btc) are induced in cumulus oocyte complexes ( COCs) by autocrine and paracrine mechanisms that involve the actions of prostaglandins ( PGs) and progesterone receptor ( PGR). Areg and Ereg mRNA and protein levels were reduced significantly in COCs and ovaries collected from prostaglandin synthase 2 ( Ptgs2) null mice and Pgr null ( PRKO) mice at 4 h and 8 h after human chorionic gonadotropin, respectively. In cultured COCs, FSH/forskolin induced Areg mRNA within 0.5 h that peaked at 4 h, a process blocked by inhibitors of p38MAPK ( SB203580), MAPK kinase (MEK) 1 ( PD98059), and PTGS2 ( NS398) but not protein kinase A ( PKA) ( KT5720). Conversely, AREG but not FSH induced Ptsg2 mRNA at 0.5 h with peak expression of Ptgs2 and Areg mRNAs at 4 h, processes blocked by the EGF receptor tyrosine kinase inhibitor AG1478 ( AG), PD98059, and NS398. PGE2 reversed the inhibitory effects of AG on AREG-induced expression of Areg but not Ptgs2, placing Ptgs2 downstream of EGF-R signaling. Phorbol 12- myristate 13-acetate (PMA) and adenovirally expressed PGRA synergistically induced Areg mRNA in granulosa cells. In COCs, AREG not only induced genes that impact matrix formation but also genes involved in steroidogenesis ( StAR, Cyp11a1) and immune cell-like functions (Pdcd1, Runx1, Cd52). Collectively, FSH-mediated induction of Areg mRNA via p38MAPK precedes AREG induction of Ptgs2 mRNA via ERK1/2. PGs acting via PTGER2 in cumulus cells provide a secondary, autocrine pathway to regulate expression of Areg in COCs showing critical functional links between G protein- coupled receptor and growth factor receptor pathways in ovulating follicles.
dc.publisher0888-8809
dc.relation.ispartofMolecular Endocrinology
dc.sourceMolecular Endocrinology[ISSN 0888-8809],v. 20 (6), p. 1352-1365
dc.subject.otherFollicle-Stimulating-Hormone
dc.subject.otherRibonucleic-Acid Expression
dc.subject.otherLuteinizing-Hormone
dc.subject.otherEndoperoxide Synthase-2
dc.subject.otherMice Lacking
dc.subject.otherMeiotic Resumption
dc.subject.otherOvarian-Follicles
dc.subject.otherGene-Expression
dc.subject.otherFamily-Members
dc.subject.otherProtein
dc.titleParacrine and autocrine regulation of epidermal growth factor-like factors in cumulus oocyte complexes and granulosa cells: Key roles for prostaglandin synthase 2 and progesterone receptor
dc.typeinfo:eu-repo/semantics/Article
dc.typeArticle
dc.identifier.doi10.1210/me.2005-0504
dc.identifier.scopus33744464493
dc.identifier.isi000237806900017
dcterms.isPartOfMolecular Endocrinology
dcterms.sourceMolecular Endocrinology[ISSN 0888-8809],v. 20 (6), p. 1352-1365
dc.contributor.authorscopusid56212657200
dc.contributor.authorscopusid13807439800
dc.contributor.authorscopusid6507425244
dc.contributor.authorscopusid7403707010
dc.description.lastpage1365
dc.identifier.issue6
dc.description.firstpage1352
dc.relation.volume20
dc.type2Artículo
dc.identifier.wosWOS:000237806900017
dc.contributor.daisngid404030
dc.contributor.daisngid2446020
dc.contributor.daisngid2922182
dc.contributor.daisngid63955
dc.contributor.daisngid29401747
dc.identifier.investigatorRIDK-7776-2014
dc.identifier.investigatorRIDQ-3673-2016
dc.identifier.investigatorRIDK-9671-2014
dc.contributor.wosstandardWOS:Shimada, M
dc.contributor.wosstandardWOS:Hernandez-Gonzalez, I
dc.contributor.wosstandardWOS:Gonzalez-Robayna, I
dc.contributor.wosstandardWOS:Richards, JAS
dc.date.coverdateJunio 2006
dc.identifier.ulpgces
dc.description.jcr4,967
dc.description.jcrqQ1
item.grantfulltextnone-
item.fulltextSin texto completo-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.deptGIR IUIBS: Bioquímica-
crisitem.author.deptIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.deptDepartamento de Bioquímica y Biología Molecular, Fisiología, Genética e Inmunología-
crisitem.author.orcid0000-0001-8937-9034-
crisitem.author.orcid0000-0002-7650-4454-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.parentorgIU de Investigaciones Biomédicas y Sanitarias-
crisitem.author.fullNameHernández González, Inmaculada Servanda-
crisitem.author.fullNameGonzález Robayna, Ignacio Javier-
Appears in Collections:Artículos
Show simple item record

SCOPUSTM   
Citations

349
checked on Nov 24, 2024

WEB OF SCIENCETM
Citations

332
checked on Nov 24, 2024

Page view(s)

64
checked on May 18, 2024

Google ScholarTM

Check

Altmetric


Share



Export metadata



Items in accedaCRIS are protected by copyright, with all rights reserved, unless otherwise indicated.